Evidence map›Paper›PMID 28589473›Full record

ArticleClinical oral investigations2018

The effect of triclosan on posttranslational modification of proteins through citrullination and carbamylation.

Richard Bright, C Marchant, P M Bartold

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical oral investigations, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Protein carbamylation in end stage renal disease: is there a mortality effect?Current opinion in nephrology and hypertension · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Richard BrightColgate Australian Clinical Dental Research Centre, Department of Dentistry, University of Adelaide, Adelaide, South Australia, 5005, Australia. richard.bright@adelaide.edu.au.
C MarchantColgate Australian Clinical Dental Research Centre, Department of Dentistry, University of Adelaide, Adelaide, South Australia, 5005, Australia.
P M BartoldColgate Australian Clinical Dental Research Centre, Department of Dentistry, University of Adelaide, Adelaide, South Australia, 5005, Australia.
Australian Dental Association · AUUniversity of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was evaluate the effect of triclosan on citrullination and carbamylation, two important protein posttranslational modifications associated with inflammatory conditions such as periodontitis and rheumatoid arthritis. MATERIALS AND

methodsA range of triclosan concentrations were incubated in the presence of appropriate substrates used for the generation of either citrullinated or carbamylated proteins. The effect of triclosan on protein citrullination and carbamylation in macrophages was also assessed.

resultsCitrullination and carbamylation were both significantly decreased by triclosan at concentrations six times lower than the 0.3% triclosan approved by the FDA to use in mouthwash and toothpaste. When macrophages were exposed to triclosan, carbamylation was significantly deceased (p = 0.01), and while citrullination also decreased, this reduction was not statistically significant (p = 0.06).

conclusionTriclosan reduced the generation of protein citrullination and carbamylation in vitro. CLINICAL RELEVANCE: Triclosan may be useful as an adjunct therapy in the management of inflammatory periodontal diseases and help to reduce posttranslational protein modification citrullination and carbamylation) in these tissues.

Indexed as

Protein Processing, Post-TranslationalAnimalsAnti-Infective Agents, LocalCell SurvivalCitrullinationEnzyme-Linked Immunosorbent AssayHumansIn Vitro TechniquesMacrophagesPeriodontitisPorphyromonas gingivalisProtein-Arginine DeiminasesRabbitsTriclosanAnti-Infective Agents, LocalProtein-Arginine DeiminasesTriclosanCarbamylationCitrullinationPeriodontitisRheumatoid arthritisTriclosan

Identifiers

PMID28589473
OpenAlexW2624195268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.